利用游离DNA片段组学检测肝癌
本研究对来自美国、欧盟或香港的724例肝细胞癌患者或平均/高风险个体进行全基因组游离DNA片段组学分析,采用机器学习模型整合多特征片段组数据;在平均风险人群中检测癌症的敏感性为88%(特异性98%),在高风险个体中敏感性为85%(特异性80%),并在独立人群中验证了这些结果。
要点
- 基于cfDNA片段组学的机器学习模型在平均风险人群中检测肝癌敏感性88%、特异性98%。
- 在高风险个体中该模型检测肝癌敏感性85%、特异性80%。
- 结果在独立人群中得到验证,cfDNA片段变化反映肝癌基因组和染色质改变。
核心结论
- cfDNA片段组学变化为肝癌患者提供了无创检测的生物学基础,并可作为可及的非侵入性癌症检测方法。
研究设计与样本
- 研究分析了来自美国、欧盟或香港的724例肝细胞癌患者或平均/高风险个体,进行全基因组cfDNA片段组学分析,使用机器学习模型整合多特征片段组数据,并在独立人群中验证。
主要发现
- 在平均风险人群中,检测癌症的敏感性为88%,特异性为98%。
- 在高风险个体中,检测癌症的敏感性为85%,特异性为80%。
- cfDNA片段变化反映肝癌的基因组和染色质改变,包括转录因子结合位点的变化。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Liver cancer is a major cause of cancer mortality worldwide. Screening individuals at high risk, including those with cirrhosis and viral hepatitis, provides an avenue for improved survival, but current screening methods are inadequate. In this study, we used whole-genome cell-free DNA (cfDNA) fragmentome analyses to evaluate 724 individuals from the United States, the European Union, or Hong Kong with hepatocellular carcinoma (HCC) or who were at average or high-risk for HCC. Using a machine learning model that incorporated multifeature fragmentome data, the sensitivity for detecting cancer was 88% in an average-risk population at 98% specificity and 85% among high-risk individuals at 80% specificity. We validated these results in an independent population. cfDNA fragmentation changes reflected genomic and chromatin changes in liver cancer, including from transcription factor binding sites. These findings provide a biological basis for changes in cfDNA fragmentation in patients with liver cancer and provide an accessible approach for noninvasive cancer detection. SIGNIFICANCE: There is a great need for accessible and sensitive screening approaches for HCC worldwide. We have developed an approach for examining genome-wide cfDNA fragmentation features to provide a high-performing and cost-effective approach for liver cancer detection. See related commentary Rolfo and Russo, p. 532. This article is highlighted in the In This Issue feature, p. 517.
引用
- Foda ZH, Annapragada AV, Boyapati K, et al. Detecting Liver Cancer Using Cell-Free DNA Fragmentomes. Cancer Discov. 2023. PMID: 36399356. doi:10.1158/2159-8290.CD-22-0659
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。